greeksoup/ stock research
Stock research / United States / HSIC · Wholesale-Medical, Dental & Hospital Equipment & Supplies · Nasdaq

Henry Schein Inc. (HSIC)

Henry Schein distributes health care products and services, mainly to office-based dental and medical practitioners and alternate sites of care, and states that it is the world's largest provider of them. With 94 years of distribution history it serves more than one million customers worldwide across dental practices, laboratories, physician practices and ambulatory surgery centres, plus government and institutional clinics and home health providers. It is headquartered in Melville, New York, employs more than 25,000 people, approximately 48% of them in the United States, and has operations or affiliates in 34 countries. It stocks more than 300,000 branded and own brand products, with over 5.4 million square feet across 38 distribution centres and 0.6 million square feet across 17 manufacturing sites. There are three reportable segments: Global Distribution and Value-Added Services, at 84.5% of consolidated net sales in 2025, Global Specialty Products at 11.7% and Global Technology at 5.1%.

Henry Schein Inc.

Henry Schein distributes health care products and services, mainly to office-based dental and medical practitioners and alternate sites of care, and states that it is the world's largest provider of them. With 94 years of distribution history it serves more than one million customers worldwide across dental practices, laboratories, physician practices and ambulatory surgery centres, plus government and institutional clinics and home health providers. It is headquartered in Melville, New York, employs more than 25,000 people, approximately 48% of them in the United States, and has operations or affiliates in 34 countries. It stocks more than 300,000 branded and own brand products, with over 5.4 million square feet across 38 distribution centres and 0.6 million square feet across 17 manufacturing sites. There are three reportable segments: Global Distribution and Value-Added Services, at 84.5% of consolidated net sales in 2025, Global Specialty Products at 11.7% and Global Technology at 5.1%.

Distribution and services

The largest segment distributes consumable products, small and large equipment, laboratory products, repair services, branded and generic pharmaceuticals, vaccines, dental specialty products, diagnostic tests, infection-control products and vitamins. A home health business ships homecare products direct to patients, covering incontinence, urology, ostomy, enteral nutrition, wound and diabetes supplies and continuous glucose monitoring devices. It runs 127 equipment sales and service centres worldwide whose manufacturer-trained technicians install and repair dental handpieces, small equipment, table-top sterilisers and large dental equipment, and value-added work includes continuing education, consulting and practice services. It also arranges financial products from third-party suppliers, including non-recourse financing for equipment, technology and software, practice and patient financing and card processing, at rates it says are generally lower than customers could get alone, plus staffing, practice valuation and brokerage. Within it, dental merchandise was 36.6% of consolidated net sales in 2025, dental equipment 13.6% and medical 32.5%.

Specialty products

The segment develops, makes and distributes dental implants, prosthetic components, instruments and digital workflow products for implant-based tooth restorations, with research and manufacturing in five countries and sales in approximately 90, plus a biomaterials range for dental tissue regeneration of privately branded allograft, xenograft and synthetic products. Orthodontics covers brackets, braces, aligners and accessories, made in the United States, Mexico and France and sold to practices in over 70 countries. Endodontics covers stainless steel and nickel titanium shaping files, irrigation solutions, power equipment, sealers and root repair materials, made in the United States, Switzerland and Brazil and marketed in over 90 countries. Orthopedics covers implants and instruments for injuries and disorders of the limbs and joints, plus surgical accessories such as blades, burs, drills, pins and wires, sold through independent agencies and direct specialists, mostly in the United States.

Technology

The segment sells practice management, business analytics, revenue cycle management, clinical workflow, artificial intelligence, patient engagement and demand creation software to dental customers, carrying electronic medical records, treatment history, billing, appointment calendars, claims processing and electronic prescribing. At 27 December 2025 the active user base was approximately 95,000 practices and 324,000 consumers, on products including Dentrix Dental Systems, Dentrix Ascend, AxiUm, EXACT and Demandforce.

Competition and supply

In United States dental distribution the main competitors are the Patterson Dental division of Patterson Companies and Benco Dental Supply, alongside national, regional and local distributors; in medical distribution, the large majority of global medical sales, they are McKesson and Medline. Outside the country the filing states that it is the only global distributor of supplies and equipment to dental practices, competing mainly with local and regional companies including Cadence Group, Proclinic Group, DD Group, Lifco, Planmeca Group and Dental Bauer. In specialty products the main implant competitors are Straumann, Envista, Zimvie and Dentsply Sirona, and in technology they include the Eaglesoft division of Patterson, Carestream Dental, Open Dental Software, PlanetDDS, Curve Dental, eClinicalWorks and Epic Systems. Specialty products are made at its 17 manufacturing sites with some work outsourced, and raw materials come from distributors or mills, no single supplier being material.

The markets and the year

It points to demographics, with the United States population aged 45 and older expected to grow by approximately 10% between 2025 and 2035 against approximately 4% for the total population. The filing states that dental spending is predicted to rise with that age group and that demand is increasing for technologies which raise dentist productivity. In the medical market it points to procedures migrating from acute-care settings to physicians' offices and the home, where the filing states the company has established a leading position as a vaccine supplier. Sales and profitability have generally been higher in the third and fourth quarters, because of seasonal products such as influenza vaccine, purchasing patterns for equipment and software, year-end promotions, dental tradeshows, and practices delaying equipment purchases for tax reasons.

From Henry Schein's annual report on Form 10-K for the year ended 27 December 2025. The filing

Compare with another name What $10,000 in Henry Schein became

Latest results

Latest quarterQ3 FY2026ended 26 September 2026 · 10-Q filed 3 November 2026
Revenue
$3.5 billion
+4.0% on the year · +0.4% on the quarter
Q4 FY2024Q3 FY2026
Net income
$119 million
+17.8% on the year · +26.6% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$1.06
+26.2% on the year · +29.3% on the quarter
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Last full yearFY2025ended 27 December 2025 · 10-K filed 24 February 2026
Revenue
$13.2 billion
+4.0% on the year
FY2018FY2025
Net income
$398 million
+2.1% on the year
FY2018FY2025
Diluted EPS
$3.27
+7.2% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The years before, in wordsHenry Schein (HSIC) reported revenue of $13.2 billion for fiscal 2025, the year ended 27 December 2025, up 4.0% on the year before. Net income was $398 million and diluted earnings per share $3.27. Revenue was $12.7 billion in fiscal 2024, $12.3 billion in fiscal 2023, $12.6 billion in fiscal 2022 and $12.4 billion in fiscal 2021. Net income in the same years was $390 million, $416 million, $538 million and $631 million. Over the twelve months to 26 September 2026, Henry Schein reported revenue of $13.7 billion and net income of $421 million. Revenue grew 5.4% a year, compounded, over the five years to fiscal 2025. Henry Schein had 111 million shares outstanding at the latest filed count. At 26 September 2026 it carried $3.5 billion of debt and $184 million of cash. At the close of 6 November 2026 the market cap of Henry Schein was $9.5 billion, 23.6 times its earnings over the last twelve months.

Ratios

From the filings

ROE13.3%
ROCE10.6%
Operating margin5.2%
Net margin3.1%
FCF margin4.1%
Interest cover4.3x
Debt to equity1.12x
Cash conversion1.63x
Share count, last 12 months-6.8%
Sales CAGR, 3 years1.4%
Profit CAGR, 3 years-9.6%
EPS, TTM$3.65

At the close of 6 November 2026

Price$86.06
Market cap$9.5 billion
Stock P/E23.6x
Price to book3.0x
EV / EBITDA12.3x
Dividend yieldn/a
Market cap / sales0.69x
52-week high$90.86
52-week low$68.99
Price, 1 year22.8%
Price CAGR, 3 years11.0%
Price CAGR, 5 years1.4%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on the borrowing lines of Henry Schein Inc.'s balance sheet, added together, finance leases inside them only where the company puts them there; operating leases are a separate line. Nothing here is a valuation or a view.
HSICgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

Q4 FY2021 * †Q1 FY2022Q2 FY2022 †Q3 FY2022 †Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue3,3313,1793,0303,0673,3713,0603,1003,1623,0173,1723,1363,1743,1913,1683,2403,3393,4373,3683,4583,471
Cost of revenue2,3512,2062,0852,1532,3722,0942,1252,1672,0922,1602,1182,1812,1982,1682,2242,3132,3742,2982,3572,366
Gross profit9809739459149999669759959251,0121,0189939931,0001,0161,0261,0631,0701,1011,105
Gross margin29%31%31%30%30%32%31%31%31%32%32%31%31%32%31%31%31%32%32%32%
SG&A774682680648761717707725807791781724738738778760808809831819
Operating income20124422021172.017520120039.0150159157155175151164163182171193
Operating margin6%8%7%7%2%6%6%6%1%5%5%5%5%6%5%5%5%5%5%6%
Interest expense8.27.08.08.017.014.019.025.029.030.032.034.035.035.038.038.039.039.043.042.0
Pre-tax income19423921420563.016318617914.0127132128126145121134133150137160
Tax rate22%24%24%22%24%24%22%22%7%25%25%25%25%24%26%21%24%25%25%23%
Net income14718116015047.012114013718.093.010499.094.011086.010110110794.0119
Net margin4%6%5%5%1%4%5%4%1%3%3%3%3%3%3%3%3%3%3%3%
Diluted EPS$1.04$1.30$1.16$1.09$0.36$0.91$1.06$1.05$0.14$0.72$0.80$0.78$0.74$0.88$0.70$0.84$0.85$0.92$0.82$1.06
Operating cash flow27793.015798.025427.0274231-32.019729615120437.0120174381-97.0242161
Capital expenditure30.319.024.024.029.031.037.040.039.041.037.034.036.031.032.033.043.025.030.030.0
Free cash flow24674.013374.0225-4.0237191-71.01562591171686.088.0141338-122212131
Buybacks1500.011090.028510050.050.050.075.010013575.0161286203200125200125
Shares outstanding137m138m136m135m132m131m131m130m129m128m127m125m124m122m122m119m116m114m112m111m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

FY2008FY2009 †FY2010 †FY2011 †FY2012FY2013FY2014FY2015 †FY2016 †FY2017 †FY2018 †FY2019FY2020 †FY2021 †FY2022 †FY2023FY2024FY2025TTM
Revenue6,3806,5387,5278,5308,9409,56110,37110,63011,5728,8839,4189,98610,11912,40112,64712,33912,67313,18413,734
Cost of revenue4,5064,6225,3566,1126,4326,9057,4607,6178,3386,1376,5076,8957,3058,7298,8168,4788,6579,0799,395
Gross profit1,8741,9172,1712,4182,5082,6562,9113,0123,2262,7472,9113,0912,8143,6723,8313,8614,0164,1054,339
Gross margin29.4%29.3%28.8%28.3%28.0%27.8%28.1%28.3%27.9%30.9%30.9%31.0%27.8%29.6%30.3%31.3%31.7%31.1%31.6%
Selling, general and administrative1,4321,4501,6371,8361,8731,9792,1962,2382,4092,0722,2172,3582,0862,6342,7712,9563,0343,0843,267
Operating income419464521582619677715734772670601718535852747615621653709
Operating margin6.6%7.1%6.9%6.8%6.9%7.1%6.9%6.9%6.7%7.5%6.4%7.2%5.3%6.9%5.9%5.0%4.9%5.0%5.2%
Interest expense34.623.433.630.430.927.524.126.031.951.176.050.841.027.035.087.0131150163
Pre-tax income395453502569604665709721756630537680500831721542513533580
Income tax13112816018018819121621121830910716095.0198170120128126141
Effective tax rate33.2%28.2%31.9%31.7%31.1%28.7%30.4%29.3%28.8%49.1%20.0%23.4%19.0%23.8%23.6%22.1%25.0%23.6%24.3%
Net income239311326368388432466479507406536695404631538416390398421
Net margin3.8%4.8%4.3%4.3%4.3%4.5%4.5%4.5%4.4%4.6%5.7%7.0%4.0%5.1%4.3%3.4%3.1%3.0%3.1%
Diluted EPS$1.31$1.72$1.75$1.99$2.16$2.46$2.72$2.85$3.10$2.57$3.49$4.65$2.82$4.45$3.91$3.16$3.05$3.27$3.65
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Revenue by segment FY2011 to FY2025

FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
Global Distribution and Value-Added Servicesn/an/an/an/an/an/an/an/an/an/an/a10,95310,52510,72911,12084.3%
Global Specialty Productsn/an/an/an/an/an/an/an/an/an/an/a1,1451,2121,3141,38910.5%
Global Technologyn/an/an/an/an/an/an/an/an/an/an/a5496026306755.1%
Health Care Distribution8,2808,6579,24110,02310,27111,1468,5469,0099,3899,53011,754n/an/an/an/an/a
Technology and Value-Added Services251283320349359426338408515514647n/an/an/an/an/a
Global Distribution and Value-Added Services FY2022 to FY2025Global Specialty Products FY2022 to FY2025Global Technology FY2022 to FY2025Health Care Distribution FY2011 to FY2021Technology and Value-Added Services FY2011 to FY2021
8.5FY20119.6FY201310.6FY20158.9FY20179.9FY201912.4FY202112.3FY202313.2FY2025

$ billion; hover a block for its figure and share; a part named with years is one the company split its revenue into only then

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Profit by segment FY2011 to FY2025

The operating profit each segment reports. Costs Henry Schein does not charge to a segment are left out, so the segments can add up to more than the company's own operating profit.

FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Margin
FY2025
Global Distribution and Value-Added Servicesn/an/an/an/an/an/an/an/an/an/an/a8336656966806.1%
Global Specialty Productsn/an/an/an/an/an/an/an/an/an/an/a19217517824217.4%
Global Technologyn/an/an/an/an/an/an/an/an/an/an/a12514215218026.7%
Health Care Distribution512542591612627652562491591436727n/an/an/an/an/a
Technology and Value-Added Services70.177.386.410310711910811012799.0125n/an/an/an/an/a
Global Distribution and Value-Added Services FY2022 to FY2025Health Care Distribution FY2011 to FY2021Global Specialty Products FY2022 to FY2025Technology and Value-Added Services FY2011 to FY2021Global Technology FY2022 to FY2025
582FY2011677FY2013734FY2015670FY2017718FY2019852FY2021982FY20231,102FY2025

$ million; the figure over a bar is all the segments together. Hover a block for its profit, sales and margin.

FY2025Share of salesShare of profit
Global Distribution and Value-Added Services84%62%
Global Specialty Products11%22%
Global Technology5%16%

Each column adds to 100%. A segment with a bigger share of the profit than of the sales makes more on each dollar it sells.

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where every segment with sales that year has an operating profit figure. A margin is a segment's operating profit over its own sales.

Revenue by region FY2011 to FY2025

FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
United States5,2135,4975,8146,2476,7997,5376,0406,4126,8767,0908,7229,1978,6628,8259,09669.0%
Othern/an/an/an/an/an/an/an/an/an/an/an/a3,6773,8484,08831.0%
Locations other than the United States3,3173,4433,7474,1243,8314,0352,8443,0063,1103,0293,6793,450n/an/an/an/a
United StatesOther FY2023 to FY2025Locations other than the United States FY2011 to FY2022
8.5FY20119.6FY201310.6FY20158.9FY201710.0FY201912.4FY202112.3FY202313.2FY2025

$ billion; hover a block for its figure and share; a part named with years is one the company split its revenue into only then

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Cash flow

FY2008FY2009 †FY2010 †FY2011 †FY2012FY2013FY2014FY2015 †FY2016 †FY2017 †FY2018 †FY2019FY2020 †FY2021 †FY2022 †FY2023FY2024FY2025TTM
Operating cash flow385398395555408664593616643546685654599710602500848712687
Capital expenditure50.951.639.045.251.260.282.171.770.262.471.376.249.079.096.0147148139128
Free cash flow334346356509357604510544572483613578550631506353700573559
Free cash flow margin5.2%5.3%4.7%6.0%4.0%6.3%4.9%5.1%4.9%5.4%6.5%5.8%5.4%5.1%4.0%2.9%5.5%4.3%4.1%
Cash from investing-168-98.6-388-193-270n/an/a-260-316-342-193-424-115-677-276-1,135-430-400-320
Cash from financing-88.0-198-331-357-171n/an/a-348-327-113-604-216-187-333-315701-510-188-344
Depreciation and amortisation78.181.5101116125128152159170134144185186210212248297311333
Share-based compensation25.425.929.936.937.335.545.944.658.236.832.644.99.078.054.039.039.039.036.0
Buybacks82.80.057.720030030030030055045020052574.0401485250385850650
Diluted shares, weighted182m181m187m185m180m175m171m168m164m158m154m149m143m142m138m132m128m122m113m
Shares outstanding at period endn/a181m184m180m176m171m168m165m159m154m151m143m142m137m132m129m124m116m111m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

FY2008FY2009 †FY2010 †FY2011 †FY2012FY2013FY2014FY2015 †FY2016 †FY2017 †FY2018 †FY2019FY2020 †FY2021 †FY2022 †FY2023FY2024FY2025TTM
Funded by
Shareholders' equity1,7722,1612,4122,4322,6142,7852,8142,8842,7932,8112,9612,9983,3483,4253,4463,6553,3933,2453,159
Non-controlling interestn/a0.01.31.42.32.82.92.67.712.9580632636638649634638654658
Redeemable equityn/an/an/an/an/an/an/an/a286466220287328613576864806895914
Debtn/a2674414415334857318101,2199081,9407576998731,1492,3512,5363,1073,524
Operating lease liabilitiesn/an/an/an/an/an/an/an/an/an/a0.0176239268275310259251288
Finance lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/a3.73.54.06.04.03.04.0n/a
Other liabilitiesn/a1,4081,6931,8652,1852,3512,5912,8382,5073,6662,7992,2972,5192,6602,5062,7552,5833,0592,967
Total liabilities and equityn/a3,8364,5474,7405,3345,6256,1396,5356,8127,8648,5017,1517,7738,4818,60710,57310,21811,21511,510
Owned
Fixed assetsn/a260253262273276311318334375314330342366n/an/an/an/an/a
Goodwill9239861,4251,4971,6011,6351,8841,9082,0201,5542,0812,4622,5042,8542,8933,8753,8874,2134,270
Intangible assetsn/a2044054104624176445936216703765734796685879161,0231,018921
Investmentsn/a0.0n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a
Cash and equivalents37047115014712218989.572.162.417580.2106421118117171122156184
Receivablesn/a7258868881,0151,0551,1281,2301,2541,5231,1691,2461,4251,4521,4421,8631,4821,6511,875
Inventoryn/a7758709481,2041,2501,3281,5101,6661,9341,4161,4291,5121,8611,9631,8151,8102,0022,050
Other assets2,3074145585886578027559048551,6353,0651,0051,0881,1621,6051,9331,8942,1752,210
Total assets3,5993,8364,5474,7405,3345,6256,1396,5356,8127,8648,5017,1517,7738,4818,60710,57310,21811,21511,510
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded2.2%5.4%1.4%6.2%
Profit growth, compounded-1.8%-0.3%-9.6%7.7%
Return on equity, average15.5%13.8%11.7%12.3%
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was Henry Schein's revenue in fiscal 2025?

Henry Schein (HSIC) reported revenue of $13.2 billion for fiscal 2025, the year ended 27 December 2025, up 4.0% on the year before.

How much did Henry Schein earn in fiscal 2025?

Net income was $398 million for fiscal 2025, and diluted earnings per share $3.27.

What is Henry Schein's P/E ratio?

At the close of 6 November 2026, Henry Schein traded at 23.6 times its earnings over the twelve months to 26 September 2026.

What is Henry Schein's market cap?

The market cap of Henry Schein was $9.5 billion at the close of 6 November 2026.

How much debt does Henry Schein have?

At 26 September 2026 Henry Schein carried $3.5 billion of debt and $184 million of cash.

Peers: Wholesale

CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
Wesco International Inc. WCC$14.2 billion18.1714.5%5.6%13.5%1.10n/a
Watsco Inc. WSO$12.6 billion26.8815.5%9.1%0.3%0.044.1%
Domino's Pizza, Inc. DPZ$11.0 billion18.42n/a19.7%4.5%n/a2.3%
Applied Industrial Technologies Inc. AIT$10.3 billion25.0822.5%11.2%8.5%0.150.7%
Henry Schein Inc. HSIC$9.5 billion23.5813.3%5.2%6.2%1.12n/a
Arrow Electronics, Inc. ARW$9.2 billion9.1814.2%3.8%32.5%0.38n/a
Core & Main, Inc. CNM$8.8 billion18.9222.6%9.6%-0.5%1.21n/a
Qxo, Inc. QXO$8.4 billionn/a-4.9%-3.4%408.2%0.58n/a
Pool Corp. POOL$7.6 billion19.4732.3%10.5%2.9%0.952.4%
Avnet Inc. AVT$6.5 billion11.9010.7%3.3%44.3%0.791.8%
MSC Industrial Direct Co. Inc. MSM$6.3 billion28.4715.6%8.0%6.4%0.333.1%
Ingram Micro Holding Corp. INGM$6.0 billion12.8510.6%1.8%14.8%0.891.3%
All 65 in Wholesale
CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
McKesson Corp. MCK$122.5 billion27.28n/a1.6%8.2%n/a0.3%
W.W. Grainger, Inc. GWW$67.4 billion31.6549.8%15.8%9.1%0.620.7%
Cencora, Inc. COR$63.6 billion24.7886.0%0.9%5.1%3.840.7%
Cardinal Health Inc. CAH$62.9 billion35.14n/a1.0%10.0%n/a0.8%
TE Connectivity plc TEL$59.9 billion20.3022.8%19.7%16.5%0.431.4%
Ferguson Enterprises Inc. FERG$45.2 billionn/an/an/an/a0.791.4%
Sysco Corp. SYY$37.8 billion20.4544.7%3.5%3.8%3.422.8%
US Foods Holding Corp. USFD$22.9 billion29.8018.3%3.3%3.1%1.18n/a
Reliance, Inc. RS$21.3 billion19.4514.3%8.8%24.7%0.211.2%
TD Synnex Corp. SNX$17.5 billion13.3314.3%2.7%24.1%0.590.9%
Genuine Parts Co. GPC$16.9 billion491.460.7%3.6%5.3%1.103.4%
Performance Food Group Co. PFGC$16.9 billion42.837.8%1.4%5.9%1.02n/a
Wesco International Inc. WCC$14.2 billion18.1714.5%5.6%13.5%1.10n/a
Watsco Inc. WSO$12.6 billion26.8815.5%9.1%0.3%0.044.1%
Domino's Pizza, Inc. DPZ$11.0 billion18.42n/a19.7%4.5%n/a2.3%
Applied Industrial Technologies Inc. AIT$10.3 billion25.0822.5%11.2%8.5%0.150.7%
Henry Schein Inc. HSIC$9.5 billion23.5813.3%5.2%6.2%1.12n/a
Arrow Electronics, Inc. ARW$9.2 billion9.1814.2%3.8%32.5%0.38n/a
Core & Main, Inc. CNM$8.8 billion18.9222.6%9.6%-0.5%1.21n/a
Qxo, Inc. QXO$8.4 billionn/a-4.9%-3.4%408.2%0.58n/a
Pool Corp. POOL$7.6 billion19.4732.3%10.5%2.9%0.952.4%
Avnet Inc. AVT$6.5 billion11.9010.7%3.3%44.3%0.791.8%
MSC Industrial Direct Co. Inc. MSM$6.3 billion28.4715.6%8.0%6.4%0.333.1%
Ingram Micro Holding Corp. INGM$6.0 billion12.8510.6%1.8%14.8%0.891.3%
LKQ Corp. LKQ$5.1 billion20.064.0%4.8%-1.4%0.596.0%
SiteOne Landscape Supply, Inc. SITE$4.9 billion29.589.9%5.5%2.9%0.28n/a
Chefs' Warehouse, Inc. CHEF$4.2 billion44.5514.9%4.1%11.5%1.06n/a
Ashland Inc. ASH$3.5 billion67.142.7%7.4%-1.4%0.732.2%
Seaboard Corp. SEB$3.4 billion6.1410.0%2.6%7.0%0.300.3%
Hawkins Inc. HWKN$3.1 billion36.6615.2%11.1%9.0%0.410.5%
Central Garden & Pet Co. CENT$3.0 billion17.829.5%8.1%-1.2%0.68n/a
Resideo Technologies, Inc. REZI$2.9 billion8.5814.2%6.9%3.4%1.20n/a
United Natural Foods Inc. UNFI$2.7 billion33.795.2%0.7%-2.0%0.96n/a
Central Garden & Pet Co. CENTA$2.6 billion15.239.5%8.1%-1.2%0.68n/a
Boise Cascade Co. BCC$2.4 billion20.595.9%2.8%1.2%0.221.3%
Eplus Inc. PLUS$2.4 billionn/an/an/an/a0.000.8%
DXP Enterprises Inc. DXPE$2.2 billion23.3417.3%8.9%12.9%1.44n/a
PC Connection Inc. CNXN$2.0 billion19.5410.5%4.1%9.5%0.000.9%
Vestis Corp. VSTS$1.9 billionn/a-0.6%3.6%-0.4%1.240.2%
Andersons, Inc. ANDE$1.9 billion9.2615.0%n/a-4.3%0.801.5%
World Kinect Corp. WKC$1.8 billionn/a-13.1%-0.1%21.1%0.542.4%
Global Industrial Co. GIC$1.8 billion19.3325.9%8.3%10.2%0.002.4%
Distribution Solutions Group, Inc. DSGR$1.6 billion145.621.7%3.5%6.6%1.14n/a
Herbalife Ltd. HLF$1.6 billion9.10n/a9.6%6.4%n/an/a
Global Partners LP GLP$1.5 billionn/an/a1.5%29.5%n/an/a
Ryerson Holding Corp. RYZ$1.4 billionn/a1.1%1.0%53.2%0.772.7%
Gold.com, Inc. GOLD$1.1 billion12.5010.1%n/a110.1%0.002.1%
Willis Lease Finance Corp. WLFC$990 million13.5810.8%11.3%20.1%3.460.8%
Universal Corp. UVV$982 millionn/a-0.2%4.2%-9.4%0.868.4%
Scansource, Inc. SCSC$869 million13.387.4%2.5%14.8%0.36n/a
CrossAmerica Partners LP CAPL$756 million15.97n/a2.7%9.1%n/an/a
Climb Global Solutions, Inc. CLMB$740 million30.7617.7%4.0%24.2%0.000.4%
Weyco Group Inc. WEYS$586 million14.7015.0%17.1%1.5%0.005.1%
BlueLinx Holdings Inc. BXC$476 millionn/a-0.7%1.2%4.2%0.48n/a
L.B. Foster Co. FSTR$415 million30.987.4%4.4%15.8%0.15n/a
Aspen Aerogels Inc. ASPN$408 millionn/a-70.6%-59.3%-39.3%0.46n/a
Sempreon, Inc. MGPI$368 millionn/a-42.0%-57.2%-15.9%0.572.8%
Richardson Electronics, Ltd. RELL$229 million30.255.0%4.4%13.9%0.00n/a
AerSale Corp. ASLE$219 millionn/a-4.6%-3.9%-4.4%0.40n/a
NU Skin Enterprises, Inc. NUS$199 millionn/a-42.8%-2.0%-15.3%0.375.9%
Alta Equipment Group Inc. ALTG$193 millionn/an/a0.9%-1.8%n/a1.9%
Arko Petroleum Corp. APC$187 millionn/an/an/an/a0.76n/a
Hudson Technologies Inc. HDSN$176 millionn/a-0.5%0.4%2.3%0.00n/a
HF Foods Group Inc. HFFG$80 millionn/a-16.7%-2.8%2.8%0.86n/a
Capstone Holding Corp. CAPS$29 millionn/a-177.9%-17.2%38.9%2.05n/a
No other company here shares its SEC industry code (Wholesale-Medical, Dental & Hospital Equipment & Supplies); these are the names nearest in size in its wider industry, Wholesale, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on HSIC

Dividendsno dividend in its filings for fiscal 2008 onward
Filings22 in twelve months: 12 current reports (8-K), about 4 results of operations; 4 officer or director change; 3 regulation FD disclosure; 3 material agreement; 2 new financial obligation
Planned insider sales11 Form 144 notices in twelve months, $16.3 million; latest 14 August 2026
Options tapeput/call 0.38 by open interest at the 6 November 2026 close; the straddle prices a 5.4% move to 20 November 2026
13F holders570 funds reported a position for the quarter to 30 June 2026; largest Kohlberg Kravis Roberts & Co. L.P.
Insider trading10 sales and 1 purchase on Form 4 in twelve months
Congress0 House trades disclosed in six months
Short interest9.0 million shares short, 7.02 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Filings

FilingPeriodFiledWhere
10-Q26 September 20263 November 2026EDGAR
10-Q27 June 20264 August 2026EDGAR
10-Q28 March 20265 May 2026EDGAR
10-K27 December 202524 February 2026EDGAR
10-Q27 September 20254 November 2025EDGAR
10-Q28 June 20255 August 2025EDGAR
10-Q29 March 20255 May 2025EDGAR
10-K28 December 202425 February 2025EDGAR
10-Q28 September 20245 November 2024EDGAR
10-Q29 June 20246 August 2024EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.